[Labyrinthitis following the use of diphenylhydantoin].
D000328:Adult; D004359:Drug Therapy, Combination; D006801:Humans; D007759:Labyrinth Diseases / Q000139:chemically induced*; D007762:Labyrinthitis / Q000139:chemically induced*; D008297:Male; D010634:Phenobarbital / Q000627:therapeutic use; D010672:Phenytoin / Q000009:adverse effects*
D010672:Phenytoin; D010634:Phenobarbital
Labirintite consequente ao uso de difenilhidantoina.